Vanda Pharmaceuticals (VNDA) EBITDA Margin Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -1,506.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,506.00 |
| Dec 31, 2025 | -5,116.00 |
| Sep 30, 2025 | -3,244.00 |
| Jun 30, 2025 | -5,303.00 |
| Mar 31, 2025 | -6,250.00 |
| Dec 31, 2024 | -362.00 |
| Sep 30, 2024 | -770.00 |
| Jun 30, 2024 | -1,393.00 |
| Mar 31, 2024 | -2,270.00 |
| Dec 31, 2023 | -2,591.00 |
| Sep 30, 2023 | -2,137.00 |
| Jun 30, 2023 | -1,160.00 |
| Mar 31, 2023 | 1,588.00 |
| Dec 31, 2022 | -255.00 |
| Sep 30, 2022 | -948.00 |
| Jun 30, 2022 | -1,286.00 |
| Mar 31, 2022 | -2,926.00 |
| Dec 31, 2021 | -273.00 |
| Sep 30, 2021 | 250.00 |
| Jun 30, 2021 | 343.00 |
| Mar 31, 2021 | 1,666.00 |
| Dec 31, 2020 | 839.00 |
| Sep 30, 2020 | -526.00 |
| Jun 30, 2020 | -204.00 |
| Mar 31, 2020 | 407.00 |
| Dec 31, 2019 | -1,037.00 |
| Sep 30, 2019 | 528.00 |
| Jun 30, 2019 | 831.00 |
| Mar 31, 2019 | -1,008.00 |
| Dec 31, 2018 | 2,212.00 |
| Sep 30, 2018 | 2,448.00 |
| Jun 30, 2018 | 1,359.00 |
| Mar 31, 2018 | 2,753.00 |
| Dec 31, 2017 | -246.00 |
| Sep 30, 2017 | -939.00 |
| Jun 30, 2017 | 872.00 |
| Mar 31, 2017 | 1,637.00 |
| Dec 31, 2016 | 4,505.00 |
| Sep 30, 2016 | 3,196.00 |
| Jun 30, 2016 | 650.00 |
| Mar 31, 2016 | 896.00 |
| Dec 31, 2015 | -50,020.00 |
| Sep 30, 2015 | -2,387.00 |
| Jun 30, 2015 | 17,913.00 |
| Mar 31, 2015 | 24,422.00 |
| Dec 31, 2014 | 54,214.00 |
| Sep 30, 2014 | 5,257.00 |
| Jun 30, 2014 | -15,789.00 |
| Mar 31, 2014 | -23,411.00 |
| Dec 31, 2013 | -754.00 |
| Sep 30, 2013 | 273.00 |
| Jun 30, 2013 | 5,548.00 |
| Mar 31, 2013 | 4,558.00 |
| Dec 31, 2012 | -1,058.00 |
| Sep 30, 2012 | -2,377.00 |
| Jun 30, 2012 | -7,614.00 |
| Mar 31, 2012 | -10,226.00 |
| Dec 31, 2011 | -5,411.00 |
| Sep 30, 2011 | -5,158.00 |
| Jun 30, 2011 | -9,540.00 |